ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,999Medicare Part D Prescriptions Filled, Including Refills

Rank: 411 out of 2343

$338K Total Retail Price of All Prescriptions

Rank: 1101 out of 2343

532 Patients Receiving at Least One Drug in Part D
82%Patients 65 Years and Older
97% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Pennsylvania
Lower avg

Schedule Two
Controlled Substances

11% of this provider’s 532 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

2% of this provider’s 532 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

1% of this provider’s 9,557 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$31 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Pennsylvania
SIMVASTATIN 976 844 1 1
LISINOPRIL 963 830 2 3
METFORMIN HCL 555 448 3 9
GLIPIZIDE XL 494 421 10 4 84
LEVOTHYROXINE SODIUM 443 383 5 2
AMLODIPINE BESYLATE 415 391 6 5
METOPROLOL TARTRATE 413 339 7 7
OMEPRAZOLE 333 280 8 4
HYDROCHLOROTHIAZIDE 318 292 9 11
RANITIDINE HCL 293 251 10 43
TRAMADOL HCL 226 206 11 25
LANTUS 222 173 12 51
ATENOLOL 217 204 13 12
FUROSEMIDE 216 208 14 6
ALENDRONATE SODIUM 162 157 15 28
NIFEDICAL XL 144 144 16 148
GABAPENTIN 143 121 17 16
CITALOPRAM HBR 135 125 18 17
WARFARIN SODIUM 133 107 19 8
LOSARTAN POTASSIUM 128 98 20 19
ACTOS 124 116 21 125
OXYCODONE-ACETAMINOPHEN 121 105 S2 22 49
GLIPIZIDE 119 105 23 56
JANUVIA 107 97 24 50
PRAVASTATIN SODIUM 105 80 25 15
CLONIDINE HCL 98 77 26 70
ADVAIR DISKUS 91 91 27 34
DIOVAN 90 90 28 23
ATORVASTATIN CALCIUM 82 79 29 10
NAPROXEN 81 77 30 108
IBUPROFEN 80 59 31 75
DOXAZOSIN MESYLATE 80 72 31 98
ZOLPIDEM TARTRATE 74 73 33 24
TRAZODONE HCL 71 67 34 53
NIFEDIPINE ER 66 66 35 89
AZITHROMYCIN 65 57 36 39
ENALAPRIL MALEATE 62 40 37 58
MIRTAZAPINE 58 53 38 41
SERTRALINE HCL 56 46 39 20
CYCLOBENZAPRINE HCL 54 47 R 40 109
AMITRIPTYLINE HCL 52 52 R 41 117
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 16, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.